Pay in 4 interest-free payments of $6.98 Learn more
Ships within 48 hours · Estimated delivery Oct 9 - Oct 14
Medication Mechanism of Action Average Weight Loss Retatrutide Triple agonist (GLP-1, GIP, Glucagon) Up to 24% average weight loss over 48 weeks Semaglutide GLP-1 receptor agonist Up to 17% over 68 weeks Tirzepatide Dual agonist (GLP-1, GIP) Up to 25% over 52 weeks Retatrutide is used to help with weight loss
Naturally occurring peptides may sometimes provide weaker financial incentives for large-scale pharmaceutical development than newer proprietary compounds
2014;5:181 Gunnarsdottir S, Rucki M, Elfarra AA
Roche) at 37 C for 90 min
There is no reliable assurance that compounds actually contain the same active ingredient as approved drugs or are safe for human use due to a lack of testing and FDA approval
It helps improve joint mobility, flexibility, and function, reducing the risk of degenerative joint diseases like osteoarthritis
US$ 29.32
US$ 22.57
US$ 29.53
